Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 3 studies | 21% ± 3% | |
oligodendrocyte | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 33% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1326.31 | 1445 / 1445 | 100% | 17.93 | 183 / 183 |
prostate | 100% | 1588.96 | 245 / 245 | 100% | 7.25 | 502 / 502 |
uterus | 100% | 1665.44 | 170 / 170 | 100% | 7.98 | 459 / 459 |
brain | 100% | 1068.37 | 2635 / 2642 | 100% | 7.01 | 705 / 705 |
bladder | 100% | 1491.90 | 21 / 21 | 100% | 12.69 | 502 / 504 |
breast | 100% | 1318.40 | 459 / 459 | 99% | 10.64 | 1112 / 1118 |
pancreas | 100% | 973.53 | 328 / 328 | 99% | 6.97 | 177 / 178 |
thymus | 100% | 1611.27 | 653 / 653 | 99% | 7.16 | 599 / 605 |
lung | 100% | 1114.11 | 578 / 578 | 99% | 9.78 | 1142 / 1155 |
intestine | 100% | 1473.38 | 966 / 966 | 99% | 7.00 | 521 / 527 |
ovary | 100% | 1585.94 | 180 / 180 | 99% | 5.71 | 424 / 430 |
skin | 100% | 1670.87 | 1809 / 1809 | 97% | 6.30 | 459 / 472 |
stomach | 100% | 1131.24 | 359 / 359 | 97% | 6.38 | 278 / 286 |
adrenal gland | 100% | 1323.28 | 258 / 258 | 96% | 4.92 | 220 / 230 |
kidney | 100% | 1109.38 | 89 / 89 | 93% | 4.63 | 834 / 901 |
liver | 100% | 670.60 | 226 / 226 | 76% | 9.32 | 308 / 406 |
adipose | 100% | 1179.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.93 | 29 / 29 |
spleen | 100% | 1876.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.53 | 1 / 1 |
blood vessel | 100% | 1058.14 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 655.15 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 653.78 | 796 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 4.22 | 72 / 80 |
peripheral blood | 82% | 546.58 | 760 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042273 | Biological process | ribosomal large subunit biogenesis |
GO_0006413 | Biological process | translational initiation |
GO_0106035 | Biological process | protein maturation by [4Fe-4S] cluster transfer |
GO_0000723 | Biological process | telomere maintenance |
GO_0005575 | Cellular component | cellular_component |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | LTO1 |
Protein name | LTO1 maturation factor of ABCE1 (Oral cancer overexpressed 1) LTO1 maturation factor of ABCE1 (cDNA FLJ58145, highly similar to Oral cancer overexpressed protein 1) LTO1 maturation factor of ABCE1 LTO1 maturation factor of ABCE1 (Oral cancer overexpressed protein 1-A) Protein LTO1 homolog (Oral cancer-overexpressed protein 1) (Tumor-amplified and overexpressed sequence 1) |
Synonyms | TAOS1 ORAOV1 |
Description | FUNCTION: The complex LTO1:YAE1 functions as a target specific adapter that probably recruits apo-ABCE1 to the cytosolic iron-sulfur protein assembly (CIA) complex machinery . May be required for biogenesis of the large ribosomal subunit and initiation of translation . May play a role in the regulation of proline metabolism and ROS production . . |
Accessions | ENST00000535657.5 ENST00000536870.5 F5GZY6 ENST00000441922.6 F5GWS9 F5H179 F5H8D9 F5H6T8 A6YPU5 ENST00000542341.1 B4DFA5 Q8WV07 ENST00000538554.6 ENST00000539414.5 ENST00000537272.6 ENST00000535542.5 H3BPK6 ENST00000279147.9 ENST00000543562.1 |